MTX
MTX is a pharmaceutical drug with 35 clinical trials. Currently 3 active trials ongoing. Historical success rate of 87.5%.
Success Metrics
Based on 21 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
13
Mid Stage
21
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
21 of 24 finished
12.5%
3 ended early
3
trials recruiting
35
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL
Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD
MTX and Steroid as First-line Therapy for aGVHD
Clinical Trials (35)
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL
Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD
MTX and Steroid as First-line Therapy for aGVHD
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)
An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy
The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment
The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment
Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis
A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.
A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma
MTX Hold During Covid-19 Booster
Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy
Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis
Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 35